Transcatheter aortic valve implantation (TAVI) has revolutionized the treatment of severe aortic stenosis in high-risk patients, offering a minimally invasive alternative to open-heart surgery. However, complications such as hemodynamic instability may require mechanical circulatory support. In some cases, emergent cardiac surgery may be required, necessitating a swift transition to cardiopulmonary bypass (CPB). We modified the CPB circuit allowing for circulatory support and easy transition to CPB. No bleeding or vascular complications were observed. The modified CPB circuit minimizes hemodynamic disruptions and allows for postoperative ECMO support.
BlankenbergSSeiffertMVontheinR, et al.Transcatheter or surgical treatment of aortic-valve stenosis. N Engl J Med2024; 390: 1572–1583.
2.
MassonJ-BKovacJSchulerG, et al.Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications. JACC Cardiovasc Interv2009; 2: 811–820.
3.
EggebrechtHSchmermundAKahlertP, et al.Emergent cardiac surgery during transcatheter aortic valve implantation (TAVI): a weighted meta-analysis of 9,251 patients from 46 studies. EuroIntervention2013; 8: 1072–1080.
4.
LeonMBSmithCRMackM, et al.Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med2010; 363: 1597–1607.
5.
SinghVDamlujiAAMendirichagaR, et al.Elective or emergency use of mechanical circulatory support devices during transcatheter aortic valve replacement. J Intervent Cardiol2016; 29: 513–522.
6.
AlkhalilAHajjarRIbrahimH, et al.Mechanical circulatory support in transcatheter aortic valve implantation in the United States (from the National Inpatient Sample). Am J Cardiol2019; 124: 1615–1620.
7.
OrvinKPerlLLandesU, et al.Percutaneous mechanical circulatory support from the collaborative multicenter Mechanical Unusual Support in TAVI (MUST) Registry. Cathet Cardiovasc Interv2021; 98: E862–E869.
8.
SinghVPatelSVSavaniC, et al.Mechanical circulatory support devices and transcatheter aortic valve implantation (from the National Inpatient Sample). Am J Cardiol2015; 116: 1574–1580.
9.
WongASKSinSWC. Short-term mechanical circulatory support (intra-aortic balloon pump, Impella, extracorporeal membrane oxygenation, TandemHeart): a review. Ann Transl Med2020; 8(13): 829.
10.
CremersTKashemAZhaoH, et al.Cardiac device creativity and innovation under constraints: exploring trends from the food and drug administration’s device clearances and recalls. Curr Probl Cardiol2024; 49: 102781.
11.
EggebrechtHVaquerizoBMorisC, et al.Incidence and outcomes of emergent cardiac surgery during transfemoral transcatheter aortic valve implantation (TAVI): insights from the European Registry on Emergent Cardiac Surgery during TAVI (EuRECS-TAVI). Eur Heart J2018; 39: 676–684.
12.
EggebrechtHMehtaRHKahlertP, et al.Emergent cardiac surgery during transcatheter aortic valve implantation (TAVI): insights from the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry. EuroIntervention2014; 10: 975–981.
13.
VallabhajosyulaSPatlollaSHSandhyavenuH, et al.Periprocedural cardiopulmonary bypass or venoarterial extracorporeal membrane oxygenation during transcatheter aortic valve replacement: a systematic review. J Am Heart Assoc2018; 7: e009608.
14.
LiuHWangLHaoX, et al.Extracorporeal membrane oxygenation versus cardiopulmonary bypass during transcatheter aortic valve implantation: a meta-analysis of survival benefits. World J Emerg Med2024; 15: 306–310.
